AIM Vaccine Co., Ltd. engages in the research and development, manufacturing, and commercialization of vaccine products for human use in the People's Republic of China. The company markets vaccine products, including recombinant Hepatitis B vaccine (Hansenula Polymorpha); freeze-dried Human R rabies vaccine; inactivated hepatitis A virus vaccines (human diploid cell); live attenuated parotiti s vaccine; inactived HFRS Vacci